Lista de obras -

A distinct transcriptional profile in response to endothelial monocyte activating polypeptide II is partially mediated by JAK-STAT3 in murine macrophages

scientific article published on 19 June 2019

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

artículo científico publicado en 2017

Adapted approach to profile genes while reconciling Vegf-a mRNA expression in the developing and injured lung

artículo científico publicado en 2015

Aminoacyl tRNA synthetase complex interacting multifunctional protein 1 simultaneously binds Glutamyl-Prolyl-tRNA Synthetase and Scaffold Protein Aminoacyl tRNA synthetase complex interacting multifunctional protein 3 of the Multi-tRNA Synthetase Co

artículo científico publicado en 2018

An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer

artículo científico publicado en 2009

Androgen receptor blockade in experimental combination therapy of pancreatic cancer

artículo científico publicado en 2007

Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation

artículo científico publicado en 2010

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer ⬇️

artículo científico publicado el 7 de junio de 2011

Augmentation of Nab-Paclitaxel Chemotherapy Response by Mechanistically Diverse Antiangiogenic Agents in Preclinical Gastric Cancer Models

scientific article published on 30 August 2018

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

artículo científico publicado en 2016

BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer ⬇️

artículo científico publicado el 9 de octubre de 2012

Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis

artículo científico publicado en 2014

Cavin-3 dictates the balance between ERK and Akt signaling

artículo científico publicado en 2013

Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II

artículo científico publicado en 2012

Cell-Cell Communication Breakdown and Endothelial Dysfunction

scientific article published on 31 January 2020

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma

scientific article published on 26 November 2019

Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer

artículo científico publicado en 2010

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

artículo científico publicado en 2013

Development of the Pulmonary Endothelium in Development of the Pulmonary Circulation: Vasculogenesis and Angiogenesis

article

Developmental regulation of p66Shc is altered by bronchopulmonary dysplasia in baboons and humans

artículo científico publicado en 2005

Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer

artículo científico publicado en 2019

EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer

artículo científico publicado en 2009

Emerging pulmonary vasculature lacks fate specification

artículo científico publicado en 2008

Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity

artículo científico publicado en 2016

Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling

artículo científico publicado en 2008

Endothelial-monocyte activating polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly via alpha5 beta1 integrin

artículo científico publicado en 2005

Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation ⬇️

artículo científico publicado el 3 de enero de 2012

Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer.

artículo científico publicado en 2014

Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy ⬇️

artículo científico publicado el 26 de noviembre de 2010

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.

artículo científico publicado en 2013

Ephrin-B2 Reverse Signaling Increases α5β1 Integrin–Mediated Fibronectin Deposition and Reduces Distal Lung Compliance ⬇️

artículo científico publicado el 1 de octubre de 2013

Epithelial-mesenchymal interactions are linked to neovascularization

artículo científico publicado en 2003

Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer ⬇️

artículo científico publicado el 15 de noviembre de 2012

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer ⬇️

artículo científico publicado el 18 de junio de 2012

Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development

artículo científico

Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II protein

artículo científico publicado en 2006

In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.

artículo científico publicado en 2004

Influence of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 on Epithelial Differentiation and Organization During Lung Development

artículo científico publicado en 2020

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

artículo científico publicado en 2017

Lung self-assembly is modulated by tissue surface tensions

artículo científico publicado en 2010

Mechanistic regulation of SPHK1 expression and translocation by EMAP II in pulmonary smooth muscle cells

artículo científico publicado en 2020

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer.

artículo científico publicado en 2014

Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motility

artículo científico publicado en 2018

Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia

artículo científico publicado en 2004

Potential role for antiangiogenic proteins in the myocardial infarction repair process

scientific journal article

Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer

artículo científico publicado en 2009

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer ⬇️

artículo científico publicado el 12 de enero de 2011

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma.

artículo científico publicado en 2018

Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer

artículo científico publicado en 2013

The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein

artículo científico publicado en 2015

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

artículo científico publicado en 2013

The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

artículo científico publicado en 2012

Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.

artículo científico publicado en 2019

Toward the elimination of bias in Pediatric Research

artículo científico publicado en 2019

Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).

artículo científico publicado en 2014

α5β1 integrin mediates pulmonary epithelial cyst formation

artículo científico publicado en 2017

Lista de obras de

A distinct transcriptional profile in response to endothelial monocyte activating polypeptide II is partially mediated by JAK-STAT3 in murine macrophages

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

Adapted approach to profile genes while reconciling Vegf-a mRNA expression in the developing and injured lung

Aminoacyl tRNA synthetase complex interacting multifunctional protein 1 simultaneously binds Glutamyl-Prolyl-tRNA Synthetase and Scaffold Protein Aminoacyl tRNA synthetase complex interacting multifunctional protein 3 of the Multi-tRNA Synthetase Co

An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer

Androgen receptor blockade in experimental combination therapy of pancreatic cancer

Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer ⬇️

Augmentation of Nab-Paclitaxel Chemotherapy Response by Mechanistically Diverse Antiangiogenic Agents in Preclinical Gastric Cancer Models

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer ⬇️

Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis

Cavin-3 dictates the balance between ERK and Akt signaling

Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II

Cell-Cell Communication Breakdown and Endothelial Dysfunction

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma

Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

Development of the Pulmonary Endothelium in Development of the Pulmonary Circulation: Vasculogenesis and Angiogenesis

Developmental regulation of p66Shc is altered by bronchopulmonary dysplasia in baboons and humans

Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer

EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer

Emerging pulmonary vasculature lacks fate specification

Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity

Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling

Endothelial-monocyte activating polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly via alpha5 beta1 integrin

Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation ⬇️

Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer.

Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy ⬇️

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.

Ephrin-B2 Reverse Signaling Increases α5β1 Integrin–Mediated Fibronectin Deposition and Reduces Distal Lung Compliance ⬇️

Epithelial-mesenchymal interactions are linked to neovascularization

Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer ⬇️

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer ⬇️

Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development

Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II protein

In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.

Influence of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 on Epithelial Differentiation and Organization During Lung Development

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

Lung self-assembly is modulated by tissue surface tensions

Mechanistic regulation of SPHK1 expression and translocation by EMAP II in pulmonary smooth muscle cells

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer.

Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motility

Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia

Potential role for antiangiogenic proteins in the myocardial infarction repair process

Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer ⬇️

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma.

Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer

The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.

Toward the elimination of bias in Pediatric Research

Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).

α5β1 integrin mediates pulmonary epithelial cyst formation